Bartrum W. Baker

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Philippe Moreau, Tamás Masszi, Norbert Grząśko et al. · New England Journal of Medicine · 2016 · 1K citations · Full text

Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Paul G. Richardson, Shaji Kumar, Tamás Masszi et al. · Journal of Clinical Oncology · 2021 · 97 citations · Full text

Ixazomib, an Investigational Oral Proteasome Inhibitor (PI), in Combination with Lenalidomide and Dexamethasone (IRd), Significantly Extends Progression-Free Survival (PFS) for Patients (Pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): The Phase 3 Tourmaline-MM1 Study (NCT01564537)

Philippe Moreau, Tamás Masszi, Norbert Grząśko et al. · Blood · 2015 · 66 citations

Transfusion transmitted <i>Yersinia enterocolitica</i> infection in New Zealand

Edward Theakston, Bartrum W. Baker, Arthur J. Morris et al. · Australian and New Zealand Journal of Medicine · 1997 · 50 citations

Anaemia is highly prevalent among unselected internal medicine inpatients and is associated with increased mortality, earlier readmission and more prolonged hospital stay: an observational retrospective cohort study

R. L. Nathavitharana, Jamie Murray, N. D'Sousa et al. · Internal Medicine Journal · 2011 · 48 citations